Glucagon-like peptide II

DB12788InvestigationalProtein Based Therapies

Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.

Code names
GLP-2

Resolves to

Compound
UNII0825W549JCCAS223460-79-5

What you can answer from here — as of December 09, 2025

8Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Glucagon-like peptide II, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In